These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21576247)

  • 1. Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.
    Henriques ST; Huang YH; Rosengren KJ; Franquelim HG; Carvalho FA; Johnson A; Sonza S; Tachedjian G; Castanho MA; Daly NL; Craik DJ
    J Biol Chem; 2011 Jul; 286(27):24231-41. PubMed ID: 21576247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulations support a preference of cyclotide kalata B1 for phosphatidylethanolamine phospholipids.
    Roseli RB; Huang YH; Henriques ST; Kaas Q; Craik DJ
    Biochim Biophys Acta Biomembr; 2024 Mar; 1866(3):184268. PubMed ID: 38191035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.
    Henriques ST; Huang YH; Castanho MA; Bagatolli LA; Sonza S; Tachedjian G; Daly NL; Craik DJ
    J Biol Chem; 2012 Sep; 287(40):33629-43. PubMed ID: 22854971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kalata B1 and Kalata B2 Have a Surfactant-Like Activity in Phosphatidylethanolomine-Containing Lipid Membranes.
    Cranfield CG; Henriques ST; Martinac B; Duckworth P; Craik DJ; Cornell B
    Langmuir; 2017 Jul; 33(26):6630-6637. PubMed ID: 28605904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The self-association of the cyclotide kalata B2 in solution is guided by hydrophobic interactions.
    Rosengren KJ; Daly NL; Harvey PJ; Craik DJ
    Biopolymers; 2013 Sep; 100(5):453-60. PubMed ID: 23893463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cyclotide Kalata B1 protein with model cellular membranes of varied electrostatics.
    Gupta R; Kumari J; Pati S; Singh S; Mishra M; Ghosh SK
    Int J Biol Macromol; 2021 Nov; 191():852-860. PubMed ID: 34592223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions.
    Wang CK; Wacklin HP; Craik DJ
    J Biol Chem; 2012 Dec; 287(52):43884-98. PubMed ID: 23129773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Synthetic mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptor.
    Sando L; Henriques ST; Foley F; Simonsen SM; Daly NL; Hall KN; Gustafson KR; Aguilar MI; Craik DJ
    Chembiochem; 2011 Nov; 12(16):2456-62. PubMed ID: 21928440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Silico Template Selection of In-Vitro Evolved Kalata B1 of Oldenlandia Affinis for Scaffolding Peptide-Based Drug Design.
    Senthilkumar B; Kumar P; Rajasekaran R
    J Cell Biochem; 2016 Jan; 117(1):66-73. PubMed ID: 26052694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance.
    Kamimori H; Hall K; Craik DJ; Aguilar MI
    Anal Biochem; 2005 Feb; 337(1):149-53. PubMed ID: 15649388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.
    Grage SL; Sani MA; Cheneval O; Henriques ST; Schalck C; Heinzmann R; Mylne JS; Mykhailiuk PK; Afonin S; Komarov IV; Separovic F; Craik DJ; Ulrich AS
    Biophys J; 2017 Feb; 112(4):630-642. PubMed ID: 28256223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclotides as natural anti-HIV agents.
    Ireland DC; Wang CK; Wilson JA; Gustafson KR; Craik DJ
    Biopolymers; 2008; 90(1):51-60. PubMed ID: 18008336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.
    Plan MR; Rosengren KJ; Sando L; Daly NL; Craik DJ
    Biopolymers; 2010; 94(5):647-58. PubMed ID: 20564013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting.
    Troeira Henriques S; Huang YH; Chaousis S; Wang CK; Craik DJ
    Chembiochem; 2014 Sep; 15(13):1956-65. PubMed ID: 25099014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective membrane disruption by the cyclotide kalata B7: complex ions and essential functional groups in the phosphatidylethanolamine binding pocket.
    Strömstedt AA; Kristiansen PE; Gunasekera S; Grob N; Skjeldal L; Göransson U
    Biochim Biophys Acta; 2016 Jun; 1858(6):1317-27. PubMed ID: 26878982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic scenario of membrane binding process of kalata b1.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    PLoS One; 2014; 9(12):e114473. PubMed ID: 25473840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological activity of the prototypic cyclotide kalata b1 is modulated by the formation of multimeric pores.
    Huang YH; Colgrave ML; Daly NL; Keleshian A; Martinac B; Craik DJ
    J Biol Chem; 2009 Jul; 284(31):20699-707. PubMed ID: 19491108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prototypic Cyclotide Kalata B1 Has a Unique Mechanism of Entering Cells.
    Henriques ST; Huang YH; Chaousis S; Sani MA; Poth AG; Separovic F; Craik DJ
    Chem Biol; 2015 Aug; 22(8):1087-97. PubMed ID: 26278183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gly(6) of kalata B1 is critical for the selective binding to phosphatidylethanolamine membranes.
    Hall K; Lee TH; Daly NL; Craik DJ; Aguilar MI
    Biochim Biophys Acta; 2012 Sep; 1818(9):2354-61. PubMed ID: 22538355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
    Shenkarev ZO; Nadezhdin KD; Sobol VA; Sobol AG; Skjeldal L; Arseniev AS
    FEBS J; 2006 Jun; 273(12):2658-72. PubMed ID: 16817894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.